| 1.7 |
5.2 |
GO:0060929 |
Purkinje myocyte differentiation(GO:0003168) septum secundum development(GO:0003285) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 1.5 |
5.9 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.3 |
4.0 |
GO:0050894 |
determination of affect(GO:0050894) |
| 1.3 |
7.9 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 1.3 |
3.8 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 1.1 |
3.4 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 1.1 |
3.4 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.1 |
3.4 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.1 |
3.2 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 1.1 |
4.2 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 1.1 |
4.2 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 1.0 |
4.2 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 1.0 |
3.0 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.9 |
2.6 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.8 |
2.5 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.8 |
2.5 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.8 |
0.8 |
GO:1902229 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 0.8 |
4.5 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.7 |
2.8 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.7 |
2.0 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.7 |
3.4 |
GO:2000691 |
regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.6 |
4.5 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.6 |
3.2 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.6 |
5.1 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.6 |
1.9 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.6 |
2.5 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.6 |
1.8 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.6 |
1.8 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.6 |
2.9 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.6 |
1.7 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.5 |
1.6 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.5 |
0.5 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.5 |
0.5 |
GO:0010656 |
negative regulation of muscle cell apoptotic process(GO:0010656) |
| 0.5 |
0.5 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.5 |
6.1 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.5 |
1.0 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.5 |
1.5 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.5 |
1.5 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.5 |
1.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.5 |
2.7 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.5 |
3.6 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.4 |
1.3 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.4 |
0.9 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.4 |
1.3 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.4 |
2.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.4 |
2.2 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.4 |
1.3 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.4 |
2.6 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
1.7 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.4 |
0.9 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.4 |
1.3 |
GO:0070429 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.4 |
2.5 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.4 |
0.4 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.4 |
0.4 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.4 |
6.1 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.4 |
2.4 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.4 |
1.2 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.4 |
2.3 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.4 |
1.2 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.4 |
2.3 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.4 |
4.5 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.4 |
0.8 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.4 |
1.9 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.4 |
4.1 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.4 |
0.4 |
GO:1901028 |
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
| 0.4 |
2.2 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.4 |
1.5 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.4 |
1.5 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.4 |
1.4 |
GO:0061324 |
glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.4 |
2.5 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.4 |
2.5 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.4 |
1.8 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.3 |
1.4 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.3 |
1.0 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.3 |
0.3 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.3 |
4.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.3 |
1.4 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.3 |
2.4 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.3 |
1.4 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.3 |
3.4 |
GO:0009176 |
pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
| 0.3 |
1.7 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.3 |
2.7 |
GO:0045007 |
depurination(GO:0045007) |
| 0.3 |
2.7 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 0.3 |
1.0 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 |
0.3 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.3 |
1.0 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.3 |
1.3 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.3 |
1.3 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.3 |
2.6 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.3 |
1.6 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.3 |
2.9 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.3 |
0.3 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.3 |
1.3 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.3 |
0.9 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.3 |
1.6 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.3 |
1.2 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 |
1.5 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.3 |
1.5 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.3 |
0.9 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 |
1.5 |
GO:1990869 |
response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.3 |
1.8 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.3 |
1.8 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 |
3.9 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.3 |
3.6 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.3 |
0.6 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.3 |
0.9 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.3 |
0.9 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.3 |
0.9 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.3 |
0.3 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.3 |
1.2 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.3 |
0.9 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.3 |
0.9 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.3 |
0.3 |
GO:2000583 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.3 |
1.2 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.3 |
0.9 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.3 |
1.4 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.3 |
0.9 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.3 |
5.4 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
0.9 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.3 |
0.3 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.3 |
0.6 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.3 |
0.3 |
GO:0060775 |
mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 0.3 |
1.1 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.3 |
0.8 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.3 |
2.2 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.3 |
0.3 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 |
0.3 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.3 |
0.8 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.3 |
0.3 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.3 |
1.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 |
2.2 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.3 |
0.5 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.3 |
1.1 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.3 |
0.8 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.3 |
0.8 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.3 |
0.5 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.3 |
1.1 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.3 |
0.8 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.3 |
0.5 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 |
0.8 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
2.7 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.3 |
0.3 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.3 |
2.7 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.3 |
1.0 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.3 |
0.3 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.3 |
0.3 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.3 |
0.8 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.3 |
2.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
3.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.3 |
1.6 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 |
2.1 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.3 |
0.3 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.3 |
1.0 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.3 |
0.8 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 |
0.8 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 |
3.1 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.3 |
0.3 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.3 |
0.8 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.3 |
0.8 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.3 |
0.3 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.3 |
0.8 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.2 |
1.7 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.2 |
4.5 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
1.0 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.2 |
0.7 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
0.7 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.2 |
0.7 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 |
0.5 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.2 |
0.2 |
GO:2000738 |
positive regulation of stem cell differentiation(GO:2000738) |
| 0.2 |
0.7 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.2 |
0.7 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.2 |
1.7 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.2 |
1.7 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.2 |
2.2 |
GO:0046959 |
habituation(GO:0046959) |
| 0.2 |
0.5 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.2 |
1.9 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.2 |
0.2 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.2 |
1.9 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
1.7 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.2 |
1.0 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.2 |
0.7 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.2 |
0.7 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 |
1.0 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.2 |
0.5 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
0.5 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.2 |
0.7 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.2 |
0.9 |
GO:0044053 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.2 |
0.5 |
GO:0021846 |
cell proliferation in forebrain(GO:0021846) |
| 0.2 |
0.9 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.2 |
2.8 |
GO:1904869 |
regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.2 |
3.5 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 |
2.1 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.2 |
2.1 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.2 |
0.2 |
GO:1900120 |
regulation of receptor binding(GO:1900120) |
| 0.2 |
0.2 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.2 |
0.2 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.2 |
0.7 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.2 |
0.7 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.2 |
1.3 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.2 |
0.4 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.2 |
0.4 |
GO:0090291 |
negative regulation of osteoclast proliferation(GO:0090291) |
| 0.2 |
0.7 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.2 |
1.6 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.9 |
GO:0052214 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.2 |
1.1 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.2 |
0.7 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.2 |
0.2 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 |
0.2 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.2 |
0.7 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.2 |
2.2 |
GO:0003352 |
regulation of cilium movement(GO:0003352) |
| 0.2 |
0.4 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 |
0.7 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 |
0.2 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
| 0.2 |
1.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
1.1 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.2 |
0.2 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.2 |
2.6 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
2.2 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.2 |
3.7 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
4.7 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 |
4.7 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 |
0.4 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.2 |
2.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.2 |
1.7 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 |
0.4 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.2 |
1.1 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.2 |
0.8 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
0.2 |
GO:0019471 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
| 0.2 |
0.8 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.2 |
0.2 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.2 |
1.5 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.2 |
1.9 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
0.2 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
0.4 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.2 |
1.2 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.2 |
0.2 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.2 |
0.6 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
2.6 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
1.2 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.2 |
2.8 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
0.6 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.2 |
0.2 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.2 |
0.8 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
0.4 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.2 |
4.8 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 |
2.0 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.2 |
0.6 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.2 |
0.4 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.2 |
1.0 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.2 |
0.4 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.2 |
0.8 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.4 |
GO:0007569 |
cell aging(GO:0007569) |
| 0.2 |
1.4 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.2 |
5.5 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
0.6 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.2 |
0.2 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.2 |
0.2 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
1.4 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.2 |
1.0 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 |
2.5 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 |
0.6 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.2 |
0.4 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.2 |
0.8 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.2 |
3.5 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
1.3 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.2 |
0.6 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.2 |
1.5 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.2 |
1.3 |
GO:1903307 |
positive regulation of regulated secretory pathway(GO:1903307) |
| 0.2 |
0.6 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
0.9 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.2 |
0.2 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.2 |
0.8 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.2 |
0.6 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.2 |
0.6 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.2 |
1.5 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.2 |
0.2 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.2 |
0.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.2 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.2 |
0.6 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.2 |
0.6 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 |
0.6 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.2 |
1.3 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
0.9 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.2 |
0.4 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 |
0.5 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.2 |
0.5 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 |
0.5 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.2 |
0.4 |
GO:0051928 |
positive regulation of calcium ion transport(GO:0051928) |
| 0.2 |
0.5 |
GO:0021834 |
chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
| 0.2 |
1.6 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.2 |
1.3 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.2 |
2.0 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
2.3 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.2 |
0.9 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.2 |
1.3 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.2 |
0.5 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.2 |
0.5 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.2 |
1.2 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.2 |
1.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 |
0.5 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.2 |
1.1 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.2 |
0.7 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.2 |
1.1 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 |
0.4 |
GO:0072229 |
proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 0.2 |
0.4 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.2 |
0.4 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.2 |
0.2 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.2 |
1.4 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.2 |
0.9 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.2 |
0.7 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 |
0.7 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 |
0.5 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.2 |
0.9 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
0.9 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.2 |
3.3 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
0.3 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) |
| 0.2 |
1.0 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 |
2.4 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 |
0.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.2 |
0.2 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 |
1.0 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 |
2.0 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
1.3 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.2 |
0.3 |
GO:0060921 |
sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) |
| 0.2 |
1.7 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 |
0.3 |
GO:0051295 |
uropod organization(GO:0032796) establishment of meiotic spindle localization(GO:0051295) |
| 0.2 |
2.3 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.2 |
5.5 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
0.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
0.3 |
GO:0044111 |
development involved in symbiotic interaction(GO:0044111) |
| 0.2 |
0.7 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
0.2 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 |
0.7 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 |
1.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.2 |
0.7 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.2 |
1.1 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.2 |
2.0 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 |
0.7 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.2 |
2.3 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.2 |
4.9 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.2 |
0.2 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.2 |
1.1 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.2 |
2.3 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.2 |
0.5 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.2 |
2.1 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
1.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
0.8 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
3.1 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 |
0.3 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 |
0.5 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.2 |
1.0 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.2 |
0.2 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.2 |
0.8 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.2 |
1.0 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
0.5 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 |
0.5 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.2 |
0.5 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 |
0.5 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 |
0.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
0.5 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.2 |
0.2 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.2 |
0.6 |
GO:0051167 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.2 |
1.4 |
GO:0090063 |
positive regulation of microtubule nucleation(GO:0090063) |
| 0.2 |
0.9 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.2 |
1.2 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.2 |
0.2 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.2 |
0.5 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 |
0.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
1.5 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.2 |
1.9 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 |
0.3 |
GO:0000819 |
sister chromatid segregation(GO:0000819) |
| 0.2 |
0.8 |
GO:1901545 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.2 |
0.2 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 |
0.5 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.2 |
0.9 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 |
0.6 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.2 |
3.5 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
0.2 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 |
0.5 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.2 |
2.0 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
0.2 |
GO:0051664 |
nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
| 0.2 |
0.9 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 |
0.5 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.2 |
0.2 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 |
1.2 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.2 |
0.2 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) |
| 0.2 |
0.3 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.2 |
1.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.6 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.9 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.4 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.1 |
0.4 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.1 |
1.3 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.1 |
0.7 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 |
1.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.1 |
0.6 |
GO:0071283 |
cellular response to iron(III) ion(GO:0071283) |
| 0.1 |
0.9 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 |
0.9 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.4 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.1 |
0.7 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
| 0.1 |
0.3 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.1 |
0.4 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
0.3 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.9 |
GO:0061188 |
negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 |
0.3 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.3 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.3 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
4.7 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.1 |
3.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
1.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
1.5 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.3 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
0.3 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.1 |
0.6 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.1 |
0.4 |
GO:0098868 |
bone growth(GO:0098868) |
| 0.1 |
2.0 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.9 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 |
0.3 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.1 |
0.6 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.1 |
1.3 |
GO:0019184 |
glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 |
0.1 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.1 |
0.3 |
GO:0051654 |
establishment of mitochondrion localization(GO:0051654) |
| 0.1 |
0.1 |
GO:0002085 |
inhibition of neuroepithelial cell differentiation(GO:0002085) |
| 0.1 |
0.4 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.7 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
2.4 |
GO:0009755 |
hormone-mediated signaling pathway(GO:0009755) |
| 0.1 |
0.4 |
GO:0071262 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.1 |
0.1 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.1 |
0.8 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.6 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
0.6 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.6 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.1 |
0.1 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.1 |
2.4 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.4 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 |
0.8 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.4 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 |
0.4 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.1 |
0.6 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.1 |
0.7 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.1 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.1 |
0.6 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.3 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 |
0.6 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
0.3 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.1 |
0.4 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
| 0.1 |
0.8 |
GO:0042560 |
folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 |
1.0 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.8 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.1 |
0.4 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.4 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.5 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 |
0.8 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.1 |
0.7 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.1 |
0.8 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
2.6 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
2.7 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.7 |
GO:0048070 |
regulation of developmental pigmentation(GO:0048070) |
| 0.1 |
0.5 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.4 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.1 |
GO:0051466 |
positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.1 |
1.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.8 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.3 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 |
0.1 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.7 |
GO:0071874 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 |
0.5 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.1 |
0.7 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) cellular lipid biosynthetic process(GO:0097384) |
| 0.1 |
0.8 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
1.4 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.3 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.1 |
0.3 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.1 |
1.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.4 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.5 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 |
0.1 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 |
0.6 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 |
0.9 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 |
0.3 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.6 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 |
0.4 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
0.9 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
0.9 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
1.4 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
0.1 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 |
0.5 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.1 |
2.2 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
1.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
2.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.5 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
3.8 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.1 |
0.3 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.1 |
0.1 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.1 |
0.1 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 0.1 |
0.5 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.1 |
2.0 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.1 |
13.8 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 |
0.8 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.3 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.8 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.4 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.1 |
0.6 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
1.4 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.4 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.1 |
0.9 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
1.2 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.4 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.5 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.6 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.4 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.1 |
1.0 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 |
1.1 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 |
1.0 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 |
1.4 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.1 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.1 |
4.9 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.1 |
1.0 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.2 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.1 |
0.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
2.1 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) |
| 0.1 |
1.0 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.2 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.1 |
0.1 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.1 |
0.4 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.8 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.1 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.1 |
0.5 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
1.3 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.6 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
1.2 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.1 |
0.4 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.1 |
0.4 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
0.4 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.1 |
0.5 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.4 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.1 |
0.5 |
GO:0071332 |
cellular response to fructose stimulus(GO:0071332) |
| 0.1 |
0.5 |
GO:0021877 |
forebrain neuron fate commitment(GO:0021877) |
| 0.1 |
0.1 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.1 |
0.5 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.1 |
0.7 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.1 |
0.4 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.1 |
0.6 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
0.1 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 |
0.4 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.1 |
0.5 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 |
0.6 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.6 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.1 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 0.1 |
0.7 |
GO:0060556 |
regulation of vitamin D biosynthetic process(GO:0060556) |
| 0.1 |
0.2 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.1 |
0.4 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
0.1 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.1 |
0.2 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.1 |
2.3 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.3 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
1.4 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 |
0.8 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.3 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.1 |
1.4 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.1 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.1 |
0.1 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.1 |
0.6 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.2 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
1.0 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 |
0.5 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
0.1 |
GO:0050976 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.1 |
1.1 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.1 |
GO:0006293 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.1 |
0.3 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.2 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
0.3 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.3 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 |
0.7 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.1 |
0.3 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
2.0 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.1 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.1 |
0.4 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
0.9 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
2.8 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.4 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.2 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.1 |
0.1 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.3 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
0.2 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.7 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.3 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.1 |
0.4 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.1 |
0.8 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.5 |
GO:0032648 |
regulation of interferon-beta production(GO:0032648) |
| 0.1 |
0.9 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.4 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.1 |
0.2 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 0.1 |
0.2 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) |
| 0.1 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.5 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
0.4 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 |
0.5 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.2 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
0.5 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 |
0.4 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
1.4 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 |
0.6 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.6 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.4 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.3 |
GO:1901340 |
negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.1 |
0.1 |
GO:1901623 |
regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.1 |
0.1 |
GO:0071288 |
cellular response to mercury ion(GO:0071288) |
| 0.1 |
1.4 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 |
1.2 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.1 |
0.3 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.1 |
1.0 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
1.2 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.1 |
1.0 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
1.3 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.1 |
0.5 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
2.5 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.1 |
GO:0071373 |
cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.1 |
0.4 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.1 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.1 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 |
2.3 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.1 |
3.1 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 0.1 |
0.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.3 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.3 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.5 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
1.0 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.3 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.1 |
0.2 |
GO:2001301 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.1 |
4.1 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.1 |
0.4 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.1 |
0.2 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.1 |
0.6 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.6 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 |
1.1 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 |
0.6 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.4 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
0.1 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
1.9 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
4.9 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.1 |
0.5 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
0.3 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.1 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.1 |
1.0 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
3.6 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.1 |
1.0 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.1 |
0.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
1.0 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
1.1 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.1 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.1 |
0.7 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
0.3 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
14.5 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.8 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
0.1 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.1 |
1.7 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
0.3 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
1.5 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 |
0.4 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
1.0 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.1 |
0.5 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
0.2 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 |
0.3 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
1.0 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.2 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 0.1 |
0.1 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.1 |
0.9 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.1 |
GO:0016070 |
RNA metabolic process(GO:0016070) |
| 0.1 |
0.7 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 |
1.0 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
1.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.4 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.6 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.1 |
0.5 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.1 |
0.3 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.1 |
0.2 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.1 |
0.6 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
0.4 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.7 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.1 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.1 |
0.3 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.1 |
0.6 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.1 |
0.1 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
0.1 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.1 |
0.7 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.4 |
GO:0045872 |
regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
2.1 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.1 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.1 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.1 |
0.7 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 |
0.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
1.5 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 |
0.3 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
0.8 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
0.9 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.4 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.1 |
0.5 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 |
0.2 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.1 |
0.1 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.1 |
0.1 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.1 |
0.2 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.6 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.1 |
0.3 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.4 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.1 |
1.7 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.2 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.1 |
0.3 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.1 |
0.2 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.1 |
0.4 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
4.8 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 |
1.7 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 |
0.5 |
GO:0021697 |
cerebellar cortex formation(GO:0021697) |
| 0.1 |
0.3 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
0.2 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 |
0.2 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
| 0.1 |
0.4 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 |
0.3 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.7 |
GO:0051410 |
detoxification of nitrogen compound(GO:0051410) |
| 0.1 |
0.3 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
0.6 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.3 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.4 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
0.7 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.9 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.1 |
0.1 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
0.3 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.5 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.1 |
0.3 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.3 |
GO:0061075 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.1 |
0.1 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.1 |
0.4 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
0.8 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.1 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.2 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 |
1.1 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.8 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.2 |
GO:1901983 |
regulation of protein acetylation(GO:1901983) |
| 0.1 |
0.8 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) |
| 0.1 |
0.9 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.1 |
0.3 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.8 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
0.1 |
GO:0038129 |
ERBB3 signaling pathway(GO:0038129) |
| 0.1 |
0.3 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.2 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.8 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.7 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
0.1 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.1 |
0.4 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.1 |
0.4 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 |
0.3 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 |
0.6 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.7 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.5 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.1 |
0.2 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 |
0.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
1.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.7 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
0.4 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.2 |
GO:0044843 |
cell cycle G1/S phase transition(GO:0044843) |
| 0.1 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
1.9 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
2.1 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.2 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.1 |
0.1 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.2 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.1 |
0.1 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) |
| 0.1 |
0.2 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.9 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.4 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) |
| 0.1 |
0.2 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.1 |
2.0 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.2 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 |
0.2 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.4 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 |
0.3 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
1.9 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 |
0.5 |
GO:0045627 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.1 |
0.1 |
GO:0098815 |
modulation of excitatory postsynaptic potential(GO:0098815) |
| 0.1 |
1.0 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.4 |
GO:0030100 |
regulation of endocytosis(GO:0030100) |
| 0.1 |
0.2 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.1 |
0.3 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 |
2.5 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.2 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.1 |
0.2 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
0.6 |
GO:0072711 |
cellular response to hydroxyurea(GO:0072711) |
| 0.1 |
0.1 |
GO:0070423 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.1 |
2.0 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
1.2 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.2 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.2 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
2.7 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.2 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 0.1 |
0.5 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.1 |
2.2 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 |
0.5 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
1.3 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.5 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
4.3 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 |
1.6 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.1 |
0.3 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) |
| 0.1 |
0.2 |
GO:0086097 |
phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 |
0.2 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.1 |
3.2 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
1.2 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.1 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 |
0.1 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.1 |
0.4 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.1 |
0.4 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 |
0.2 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.1 |
0.3 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 |
0.3 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.3 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.8 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.3 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 0.1 |
0.2 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.1 |
0.8 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.1 |
GO:0060526 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 |
0.8 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
0.7 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.4 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
5.8 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.1 |
0.3 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.2 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.1 |
0.5 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.1 |
0.2 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.5 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 |
0.1 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.8 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 |
1.0 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
2.2 |
GO:0071402 |
cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.1 |
0.4 |
GO:1904814 |
regulation of protein localization to chromosome, telomeric region(GO:1904814) |
| 0.1 |
0.2 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 |
0.2 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
3.2 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
0.2 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.1 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.1 |
2.0 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.1 |
GO:1902473 |
regulation of protein localization to synapse(GO:1902473) |
| 0.1 |
0.1 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 |
0.1 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.1 |
0.7 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.9 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.1 |
0.2 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.1 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.1 |
0.2 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
3.2 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
0.1 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 |
0.9 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
0.4 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
0.2 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.5 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 0.1 |
0.4 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.1 |
0.6 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 |
0.1 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 |
0.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.3 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 |
0.2 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.1 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.1 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.1 |
0.1 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.1 |
0.2 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.1 |
0.6 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
1.5 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.1 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.1 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
0.4 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.9 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.6 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.1 |
0.3 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.1 |
0.1 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.2 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 |
0.1 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.1 |
0.2 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 |
2.4 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.1 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 |
1.8 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.3 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.1 |
0.3 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 |
2.7 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.1 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.1 |
6.4 |
GO:0051436 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.9 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.1 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.2 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.4 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 |
0.3 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.3 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
0.7 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.1 |
GO:1902170 |
response to nitric oxide(GO:0071731) cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
| 0.1 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
4.5 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.1 |
0.4 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.1 |
1.6 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
0.1 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.1 |
0.3 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 |
0.3 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.6 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.2 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
3.0 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
1.2 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
0.7 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.8 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.3 |
GO:0009180 |
ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.1 |
0.8 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.4 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
0.3 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 |
0.3 |
GO:0032459 |
regulation of protein oligomerization(GO:0032459) |
| 0.1 |
1.0 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.1 |
0.1 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.1 |
0.3 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.3 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.1 |
0.6 |
GO:0010310 |
regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.1 |
1.2 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.1 |
3.8 |
GO:0009583 |
detection of light stimulus(GO:0009583) |
| 0.1 |
0.1 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
0.1 |
GO:0065002 |
intracellular protein transmembrane transport(GO:0065002) |
| 0.1 |
0.3 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.1 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 |
0.1 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
3.4 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.4 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.1 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.1 |
0.2 |
GO:0032275 |
luteinizing hormone secretion(GO:0032275) |
| 0.1 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.1 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 |
2.2 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
3.0 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.1 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 |
1.6 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.8 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.7 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.1 |
0.2 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.1 |
6.2 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.1 |
0.5 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.8 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.2 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.1 |
0.2 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.1 |
0.1 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.2 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 |
0.1 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.1 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.1 |
0.1 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.1 |
0.7 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.3 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.1 |
0.1 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.1 |
0.5 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
0.4 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
0.8 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.1 |
0.2 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 |
0.3 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.7 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
1.7 |
GO:0031111 |
negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
| 0.1 |
0.5 |
GO:0098927 |
vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.1 |
1.2 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.1 |
0.2 |
GO:1900005 |
positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.1 |
0.2 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.1 |
0.2 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.1 |
0.1 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.1 |
0.2 |
GO:0031333 |
negative regulation of protein complex assembly(GO:0031333) |
| 0.1 |
0.4 |
GO:0070383 |
DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
| 0.1 |
0.2 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
2.0 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.1 |
0.3 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.1 |
0.2 |
GO:0021914 |
smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 |
1.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.8 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 |
0.2 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.1 |
0.3 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.1 |
0.9 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.1 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 |
0.1 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 |
0.4 |
GO:0014733 |
regulation of skeletal muscle adaptation(GO:0014733) |
| 0.1 |
0.3 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.1 |
0.3 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
0.1 |
GO:0002717 |
positive regulation of natural killer cell mediated immunity(GO:0002717) |
| 0.1 |
0.1 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
1.0 |
GO:1904030 |
negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 |
0.2 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.1 |
0.2 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.1 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 |
1.6 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
0.2 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.1 |
1.0 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
7.7 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
1.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.5 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.9 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.4 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.1 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.1 |
GO:0097368 |
histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
0.2 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.1 |
0.1 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.1 |
0.3 |
GO:0070099 |
regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.1 |
0.1 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.4 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.1 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
0.2 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 |
0.1 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.1 |
0.6 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.8 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.1 |
GO:0072413 |
signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.1 |
0.3 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.2 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.1 |
0.1 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.1 |
0.1 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.1 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 |
0.2 |
GO:0051572 |
negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.1 |
0.2 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 |
0.1 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 |
0.4 |
GO:1902884 |
positive regulation of response to oxidative stress(GO:1902884) |
| 0.1 |
0.2 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.1 |
0.3 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 |
0.1 |
GO:1901071 |
glucosamine-containing compound metabolic process(GO:1901071) |
| 0.1 |
0.6 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
1.3 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.1 |
0.2 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.1 |
0.1 |
GO:0021626 |
hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.1 |
0.1 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 |
0.5 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) |
| 0.1 |
0.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 |
0.8 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
0.4 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.4 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.2 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 |
0.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.4 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.4 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 |
0.3 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
0.1 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 |
0.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.7 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.3 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.1 |
0.2 |
GO:0044786 |
cell cycle DNA replication(GO:0044786) |
| 0.1 |
0.2 |
GO:0001781 |
neutrophil apoptotic process(GO:0001781) |
| 0.0 |
0.2 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.1 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.0 |
0.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
2.7 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.6 |
GO:0000737 |
DNA catabolic process, endonucleolytic(GO:0000737) |
| 0.0 |
0.2 |
GO:0002888 |
positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.0 |
0.8 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
2.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.0 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.0 |
0.5 |
GO:0045930 |
negative regulation of mitotic cell cycle(GO:0045930) |
| 0.0 |
0.1 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.0 |
1.7 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.5 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.0 |
0.1 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.1 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.0 |
0.1 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.0 |
0.6 |
GO:0010737 |
protein kinase A signaling(GO:0010737) |
| 0.0 |
0.6 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
2.0 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.3 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.0 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
0.8 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.1 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.0 |
0.2 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 |
0.9 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.0 |
1.4 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
0.2 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.0 |
2.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 |
0.4 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.0 |
0.0 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.0 |
0.3 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.2 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
1.0 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.1 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.0 |
0.2 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.0 |
0.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
1.3 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 |
0.1 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.0 |
1.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
1.5 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.4 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.0 |
0.0 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.2 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
7.9 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 |
0.0 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.2 |
GO:0071697 |
ectodermal placode formation(GO:0060788) ectodermal placode morphogenesis(GO:0071697) |
| 0.0 |
0.2 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.0 |
0.4 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.4 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.0 |
0.0 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.0 |
0.1 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.0 |
1.1 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.1 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.0 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.0 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.0 |
0.4 |
GO:0031647 |
regulation of protein stability(GO:0031647) |
| 0.0 |
0.4 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.4 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.0 |
0.3 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.0 |
0.2 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.0 |
0.0 |
GO:0051584 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.0 |
0.0 |
GO:0003193 |
pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.0 |
0.1 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.0 |
0.1 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) |
| 0.0 |
0.6 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.2 |
GO:0044854 |
plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 0.0 |
0.3 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 |
0.6 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.1 |
GO:1902116 |
negative regulation of organelle assembly(GO:1902116) |
| 0.0 |
0.2 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.0 |
0.0 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.0 |
0.0 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.2 |
GO:0045209 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.0 |
0.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.4 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.2 |
GO:1904588 |
thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.0 |
0.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.3 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.4 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.8 |
GO:0046825 |
regulation of protein export from nucleus(GO:0046825) |
| 0.0 |
0.1 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 |
0.1 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.1 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
1.4 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.0 |
0.7 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.2 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.5 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.0 |
0.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.2 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.0 |
0.6 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.2 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.0 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.0 |
0.2 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
| 0.0 |
0.2 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.0 |
0.1 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 |
0.3 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.0 |
0.4 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.0 |
0.1 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.0 |
0.1 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.0 |
0.0 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.0 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.3 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.2 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.0 |
0.1 |
GO:1902080 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.0 |
0.2 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.4 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.9 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.1 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.0 |
0.7 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.9 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.0 |
0.1 |
GO:0018969 |
thiocyanate metabolic process(GO:0018969) |
| 0.0 |
0.4 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.0 |
0.4 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
0.0 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.1 |
GO:0006294 |
nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.0 |
0.2 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.0 |
0.6 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.3 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.4 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.3 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 |
0.1 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.1 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.3 |
GO:0048488 |
synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) |
| 0.0 |
0.3 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.0 |
0.1 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.0 |
0.5 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.1 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.0 |
0.1 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.0 |
0.2 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.0 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.3 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.4 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 |
0.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.4 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.0 |
0.9 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.6 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.3 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.7 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.0 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.0 |
0.2 |
GO:0042438 |
melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) |
| 0.0 |
0.2 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.0 |
0.1 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.1 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
0.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 |
0.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.6 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.0 |
0.7 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.0 |
0.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.0 |
0.0 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.0 |
0.1 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.2 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.0 |
0.2 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.0 |
0.6 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.3 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.1 |
GO:0032621 |
interleukin-18 production(GO:0032621) |
| 0.0 |
0.1 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 |
0.3 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.0 |
0.4 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.1 |
GO:0060384 |
innervation(GO:0060384) |
| 0.0 |
0.2 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.0 |
0.1 |
GO:0003188 |
heart valve formation(GO:0003188) |
| 0.0 |
0.0 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) |
| 0.0 |
0.2 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.0 |
0.1 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.0 |
0.1 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.0 |
0.1 |
GO:1901299 |
negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.0 |
0.6 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
0.4 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.2 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.1 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.2 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
1.2 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.1 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 |
0.3 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.0 |
0.6 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.1 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.0 |
0.0 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.0 |
1.3 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.1 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 |
0.3 |
GO:0038111 |
interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.0 |
0.1 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.0 |
0.2 |
GO:0044597 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 |
0.3 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.2 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
1.7 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.1 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.0 |
0.1 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.0 |
0.0 |
GO:0048875 |
surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
| 0.0 |
0.1 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.0 |
0.8 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.0 |
0.2 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.0 |
0.1 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.3 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.1 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.0 |
0.1 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.0 |
0.3 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.3 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.0 |
0.1 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.0 |
0.0 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
2.4 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.6 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
0.2 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 |
0.1 |
GO:1902750 |
negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.0 |
0.0 |
GO:0044026 |
DNA hypermethylation(GO:0044026) |
| 0.0 |
0.1 |
GO:2000641 |
regulation of early endosome to late endosome transport(GO:2000641) |
| 0.0 |
0.1 |
GO:0042559 |
pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.0 |
0.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.0 |
0.1 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.0 |
0.8 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.3 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.0 |
0.0 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
| 0.0 |
0.2 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.0 |
0.2 |
GO:0061640 |
cytoskeleton-dependent cytokinesis(GO:0061640) |
| 0.0 |
0.1 |
GO:0042490 |
mechanoreceptor differentiation(GO:0042490) inner ear receptor cell differentiation(GO:0060113) |
| 0.0 |
0.0 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.9 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.1 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.2 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.0 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.0 |
0.4 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.7 |
GO:0000731 |
DNA synthesis involved in DNA repair(GO:0000731) |
| 0.0 |
0.1 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.0 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
2.0 |
GO:0035305 |
negative regulation of dephosphorylation(GO:0035305) |
| 0.0 |
0.3 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.0 |
0.1 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.1 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.0 |
0.1 |
GO:2001205 |
negative regulation of osteoclast development(GO:2001205) |
| 0.0 |
0.6 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.0 |
0.5 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.1 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 |
0.0 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.0 |
0.1 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.0 |
0.1 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.1 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.1 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.2 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.0 |
0.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.1 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.0 |
0.1 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.0 |
0.5 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.4 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 |
0.1 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.0 |
1.4 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.2 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.0 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.1 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.2 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.0 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.0 |
0.2 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.4 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.0 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.0 |
0.0 |
GO:1901342 |
regulation of vasculature development(GO:1901342) |
| 0.0 |
0.3 |
GO:0072540 |
T-helper 17 cell lineage commitment(GO:0072540) |
| 0.0 |
0.8 |
GO:0098840 |
protein transport along microtubule(GO:0098840) |
| 0.0 |
0.0 |
GO:0030859 |
polarized epithelial cell differentiation(GO:0030859) |
| 0.0 |
0.1 |
GO:0002877 |
acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.0 |
0.0 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.0 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.2 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.0 |
0.1 |
GO:0001207 |
histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.0 |
0.1 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.0 |
0.3 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.0 |
0.1 |
GO:0031076 |
embryonic camera-type eye development(GO:0031076) |
| 0.0 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.4 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.0 |
0.1 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.0 |
0.0 |
GO:2000779 |
regulation of double-strand break repair(GO:2000779) |
| 0.0 |
0.0 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.4 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 |
0.1 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 |
0.6 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.0 |
0.0 |
GO:0046174 |
polyol catabolic process(GO:0046174) |
| 0.0 |
0.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 |
0.0 |
GO:1903979 |
regulation of microglial cell activation(GO:1903978) negative regulation of microglial cell activation(GO:1903979) |
| 0.0 |
0.4 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.0 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.0 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.4 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.4 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.2 |
GO:0043247 |
telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 |
0.0 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.0 |
0.1 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.0 |
0.1 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 |
0.1 |
GO:1901799 |
negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.0 |
0.2 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.4 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.0 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.1 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.1 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.0 |
0.1 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.0 |
0.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.0 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 |
0.3 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 |
0.2 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.0 |
0.0 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.0 |
0.0 |
GO:0061351 |
neural precursor cell proliferation(GO:0061351) |
| 0.0 |
0.2 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.0 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.0 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
1.1 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.2 |
GO:1903312 |
negative regulation of mRNA metabolic process(GO:1903312) |
| 0.0 |
0.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.1 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.4 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) |
| 0.0 |
0.1 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.3 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.0 |
0.0 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 |
0.4 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.0 |
0.0 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.2 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 |
0.0 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.0 |
0.1 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.3 |
GO:2000181 |
negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.0 |
0.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.3 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
1.0 |
GO:0071349 |
interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.0 |
0.1 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) biphenyl catabolic process(GO:0070980) |
| 0.0 |
0.0 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.1 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.0 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.0 |
0.1 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.0 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.0 |
0.0 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.0 |
0.1 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.0 |
0.1 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.0 |
0.0 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.0 |
0.1 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.0 |
0.2 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.0 |
GO:2001293 |
malonyl-CoA metabolic process(GO:2001293) |
| 0.0 |
1.0 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.0 |
0.1 |
GO:0002438 |
acute inflammatory response to antigenic stimulus(GO:0002438) |
| 0.0 |
0.0 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.1 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 |
0.1 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.2 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.0 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.0 |
0.1 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.0 |
0.1 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.0 |
0.0 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.0 |
GO:0018194 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.0 |
0.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 |
0.6 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.0 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.1 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.0 |
0.1 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 |
0.2 |
GO:0006695 |
cholesterol biosynthetic process(GO:0006695) |
| 0.0 |
0.0 |
GO:0097104 |
postsynaptic membrane assembly(GO:0097104) |
| 0.0 |
0.1 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.0 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.0 |
0.1 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.2 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.0 |
0.0 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.1 |
GO:0015692 |
lead ion transport(GO:0015692) |
| 0.0 |
0.1 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.0 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.0 |
0.0 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.3 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.1 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 |
0.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.0 |
GO:0002728 |
negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.0 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.0 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 |
0.1 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.1 |
GO:0070861 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.0 |
0.0 |
GO:0071350 |
interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 0.0 |
0.2 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.1 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.0 |
0.1 |
GO:0002070 |
epithelial cell maturation(GO:0002070) |
| 0.0 |
0.1 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 |
0.0 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.0 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.1 |
GO:0043650 |
dicarboxylic acid biosynthetic process(GO:0043650) |
| 0.0 |
0.2 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.1 |
GO:0071415 |
cellular response to purine-containing compound(GO:0071415) |
| 0.0 |
0.1 |
GO:0042339 |
keratan sulfate biosynthetic process(GO:0018146) keratan sulfate metabolic process(GO:0042339) |
| 0.0 |
0.0 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.0 |
0.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.1 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.2 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.0 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.0 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.0 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.0 |
0.4 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.0 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.0 |
0.2 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.1 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.0 |
0.0 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.0 |
0.0 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.0 |
0.0 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 |
0.0 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.1 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.0 |
0.0 |
GO:0006789 |
bilirubin conjugation(GO:0006789) |
| 0.0 |
0.0 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 |
0.1 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.0 |
GO:0071158 |
regulation of cell cycle arrest(GO:0071156) positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 |
0.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.0 |
GO:0071504 |
response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 0.0 |
0.1 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.0 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.0 |
0.5 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.4 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.2 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 |
0.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.0 |
0.1 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.0 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.2 |
GO:0006111 |
regulation of gluconeogenesis(GO:0006111) |
